Genetic and Functional Changes in Mitochondria in the Pituitary Adenoma: The Pathogenesis and Its Therapy

Antioxidants (Basel). 2024 Dec 11;13(12):1514. doi: 10.3390/antiox13121514.

Abstract

Pituitary adenoma is a common neoplasm of the pituitary gland. Although most pituitary adenomas are benign, they can pose significant challenges in terms of their consequences and prognosis due to their tendency to invade surrounding tissues and their effects on hormone secretion. The management of pituitary adenomas typically involves surgery, medical therapy, and radiotherapy, each of which has its own limitations. Mitochondria play a crucial role in tumor development and progression by regulating various metabolic processes and signaling pathways within tumor cells and the tumor microenvironment. Multiple studies have indicated that mitochondrial dysfunction is implicated in human pituitary adenomas. Furthermore, several compounds with therapeutic effects on pituitary adenomas have been reported to target mitochondrial function. In this review, we summarize recent studies that highlight the involvement of mitochondrial homeostasis imbalance in the biology of pituitary adenomas. We conclude that mitochondria may represent a promising therapeutic target for the treatment of pituitary adenomas.

Keywords: mitochondrial dysfunction; natural compounds; oxidative stress; pituitary adenomas.

Publication types

  • Review

Grants and funding

This work was supported by National Natural Science Foundation of China (32071154, 32271184, 32350025 to Z.F.; 82300902 to J.X.; 82373423 to L.H.), the Taishan Scholars Project of Shandong Province (Z.F.), the Shandong Provincial Natural Foundation (ZR2023JQ011, Z.F.), the Fund of the Zhenchi program of Tangdu Hospital (ZCJHJZRC-2021002 to L.H.), and the Opening Research Fund from Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi’an Jiaotong University (2023LHM-KFKT001, Z.F.).